Nirvana Life Sciences Inc NIRVF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- 26,000 / 26,000
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
Valuation
Metric
|
NIRVF
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
NIRVF
|
---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.05 |
Interest Coverage | −177.88 |
Quick Ratio
NIRVF
Profitability
Metric
|
NIRVF
|
---|---|
Return on Assets (Normalized) | −609.51% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
NIRVF
Biotechnology Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Novo Nordisk AS ADR
NVO
| Grdxwywjr | Dhxs | $512.4 Bil | |||
Vertex Pharmaceuticals Inc
VRTX
| Pckssgfld | Lvcrpj | $117.5 Bil | |||
Regeneron Pharmaceuticals Inc
REGN
| Xhgmmvrwk | Pzxxwc | $111.6 Bil | |||
Alnylam Pharmaceuticals Inc
ALNY
| Vmdbkkw | Cpzjsvt | $34.4 Bil | |||
argenx SE ADR
ARGX
| Kdfmqtlsh | Fjpn | $31.7 Bil | |||
BioNTech SE ADR
BNTX
| Tvcyrdlwn | Lwg | $29.2 Bil | |||
Moderna Inc
MRNA
| Hjsyjqls | Djnhw | $23.1 Bil | |||
United Therapeutics Corp
UTHR
| Xjjpbfm | Vsklx | $15.8 Bil | |||
Biomarin Pharmaceutical Inc
BMRN
| Kfrkgqtr | Vgdyhy | $13.2 Bil | |||
Incyte Corp
INCY
| Pvgrjzhch | Ljqpq | $13.0 Bil |